Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton

Episode notes

Send us Fan Mail What happens when you step back from individual biotech companies and look at the entire industry? Today's guest has spent decades connecting biotech CEOs, investors, pharmaceutical leaders, and innovators from around the world - giving her a rare front-row seat to the trends shaping the future of medicine. From AI and TechBio to venture capital, partnering, and breakthrough therapies, we're exploring where biotech is really headed next. Sara Jane Demy is the Founder and CEO of Demy-Colton ( ), one of the most influential organizations in life sciences events and ecosystem connectivity. For more than two decades, Sara has operated at the intersection of biotech innovation, venture capital, and pharma partnering - first at the Biotechnology Innovation Organization (BIO), where she helped launch major industry conferences including BIO CEO & Investor Conference, BIO Investor Forum, BIO Asia, and helped develop the partnering systems now widely used across the industry.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on Biotech81 / 100
• Success Leaves Clues: Ep 296 How Healthcare Innovation Improves Patient Access with John Leombruno, CEO at OkRx Success Leaves Clues with Robin Bailey and Al McDonald · on healthcare innovation79 / 100
• Deep Tech Gold Rush: Smart Boom or Future Bust?Venture Unlocked · on Biotech71 / 100
• Why Biology Matters: The Future of Precision and Preventive HealthcareBiology Matters · on healthcare innovation68 / 100
• The Business & Science Behind the GLP-1 BoomCareTalk: Healthcare. Unfiltered. · on healthcare innovation64 / 100
• This Just In Radio: AI in Action with Tony Nunes of AMDThis Just In Radio Show · on Drug Discovery64 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen
• RNA Medicines, Human Genetics & The Future of Obesity Treatment | Dr. Erik Ingelsson, MD, PhD - Chief Scientific Officer, Wave Life Sciences